Axiom Advisory LLC Has $1.68 Million Stake in The Clorox Company (NYSE:CLX)

Axiom Advisory LLC increased its position in The Clorox Company (NYSE:CLX) by 1.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,328 shares of the company’s stock after purchasing an additional 177 shares during the quarter. Axiom Advisory LLC’s holdings in Clorox were worth $1,679,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Rafferty Asset Management LLC boosted its holdings in Clorox by 4.3% during the fourth quarter. Rafferty Asset Management LLC now owns 9,626 shares of the company’s stock worth $1,373,000 after buying an additional 395 shares during the last quarter. Stephens Inc. AR boosted its stake in Clorox by 33.7% during the 4th quarter. Stephens Inc. AR now owns 5,229 shares of the company’s stock worth $746,000 after acquiring an additional 1,319 shares during the last quarter. Bridgewater Associates LP grew its holdings in Clorox by 2.5% during the fourth quarter. Bridgewater Associates LP now owns 170,179 shares of the company’s stock valued at $24,266,000 after purchasing an additional 4,173 shares during the period. Jacobi Capital Management LLC increased its stake in Clorox by 10.9% in the fourth quarter. Jacobi Capital Management LLC now owns 8,415 shares of the company’s stock valued at $1,200,000 after purchasing an additional 830 shares in the last quarter. Finally, Garner Asset Management Corp acquired a new stake in Clorox in the fourth quarter worth $97,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on CLX shares. Barclays upped their price objective on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. TD Cowen initiated coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Finally, Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Six analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $146.13.

Clorox Price Performance

Shares of NYSE CLX opened at $159.81 on Wednesday. The business’s 50 day moving average is $155.44 and its 200-day moving average is $144.48. The firm has a market cap of $19.85 billion, a P/E ratio of 82.80, a price-to-earnings-growth ratio of 3.31 and a beta of 0.41. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.09. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Equities research analysts predict that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.05%. Clorox’s payout ratio is presently 252.85%.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.51% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.